Views & Analysis Digital healthcare round-up: ASCO apps, public health, weara... A round-up of this week's top digital healthcare news. Marco Ricci reports.
Articles Digital health round-up: Philips' IoT, bioprinting and more A round-up of this week's top digital healthcare news. Marco Ricci reports.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.